Figure 5: Tetralinoleoyl Cardiolipin With Elamipretide Treatment

(A) The effect of HF on tetralinoleoyl cardiolipin (mass-to-charge ratio, 1,448) in untreated samples is expressed as a percentage of total cardiolipin. Elamipretide-treated (B) NF hearts or (C) HF hearts showed no changes in tetralinoleoyl cardiolipin. Untreated hearts in B and C are shown with closed circles and treated hearts with open circles. NF, n = 5; HF, n = 10. Abbreviations as in Figure 1.